HMG is strictly for laboratory research and is commonly employed in the following investigational areas:

Gonadal Hyperstimulation Models

HMG is extensively utilized in experimental models of ovarian follicular growth. Researchers employ this reagent in in vitro and in vivo models to map the dose-dependent stimulation of granulosa and theca cells, evaluating the synergistic role of LH activity alongside FSH in promoting optimal follicle maturation and estrogen synthesis.

Spermatogenesis and Testicular Bioassays

In reproductive models, researchers use HMG to study the distinct yet complementary roles of gonadotropins in male gonads. Assays focus on LH-mediated testosterone production via Leydig cells and FSH-mediated support of the seminiferous epithelium and Sertoli cell function, quantifying resulting markers of spermatogenesis.

Receptor Binding and GPCR Dynamics

Due to its dual hormone nature, HMG serves as an ideal probe for studying G protein-coupled receptor kinetics. Investigators study the simultaneous activation of FSHR and LHCGR, examining receptor dimerization, cellular internalization rates, and homologous desensitization under continuous exposure.

cAMP/PKA Pathway Profiling

Cell culture studies utilize HMG to map intracellular signal transduction. Researchers measure the rapid accumulation of intracellular cyclic AMP (cAMP) and the downstream activation of Protein Kinase A (PKA), leading to the transcription of steroidogenic acute regulatory protein (StAR) and various cytochrome P450 enzymes.

Pathway / Mechanistic Context

The primary mechanism of action for HMG in research settings involves the targeted activation of two distinct GPCR pathways.

• FSHR Activation: The FSH component binds to the FSH receptor on target cells (e.g., Sertoli or granulosa cells), coupling to the Gs-alpha protein. This directly stimulates adenylate cyclase, increasing cAMP levels and promoting the transcription of aromatase and other growth factors essential for cellular proliferation.
• LHCGR Activation: The LH component binds to the LHCGR on distinct target cells (e.g., Leydig or theca cells), similarly triggering the cAMP/PKA cascade. This distinct activation primarily drives the enzymatic conversion of cholesterol to androgens (such as testosterone or androstenedione).
• Resulting Flux: The dual-receptor engagement provides essential metabolic cross-talk. For example, in ovarian models, LH-induced androgens produced in theca cells diffuse into adjacent granulosa cells, where FSH-induced aromatase converts them into estrogens, successfully mimicking physiological steroidogenesis.

Preclinical Research Summary

Published preclinical literature documents investigations of HMG (Menotropins) across multiple experimental models for pathway characterization:

• Follicular Dynamics: Comparative studies in controlled ovarian hyperstimulation models routinely observe that HMG preparations, due to the presence of LH, provide differential follicular fluid endocrine profiles and enhanced angiogenesis markers compared to FSH-only administration.
• Leydig Cell Function: Ex vivo analyses using isolated Leydig cells show that HMG exposure significantly upregulates the expression of StAR and subsequent testosterone biosynthesis in a dose-dependent manner.
• Oocyte Competence: Research investigating the transcriptomic profiles of cumulus cells indicates that the LH activity within HMG modulates specific gene expression patterns associated with superior oocyte developmental competence and reduced cellular apoptosis.
• Steroidogenic Synergism: Endocrine pathway studies confirm that the synergistic 1:1 ratio of FSH to LH optimally maintains both the proliferative and steroidogenic capacity of gonadal tissues, preventing the premature atresia observed in models lacking sufficient LH tone.

Form & Analytical Testing

This material is produced via robust purification processes and supplied as a lyophilized (freeze-dried) powder.

• Lyophilization: Removes water content under vacuum to maintain compound integrity and extend shelf-life.
• Identity Verification: Each lot undergoes Mass Spectrometry (MS) to confirm the presence of distinct alpha and beta glycoprotein subunits.
• Purity Verification: High-Performance Liquid Chromatography (HPLC) and standardized bioassays are performed to ensure the product meets the ≥99% purity standard and the specific 75 IU FSH / 75 IU LH activity ratio required for reproducible research data.

Storage & Handling

Stable at room temperature for up to 90 days. For long-term storage, keep at -20C (-4F) or colder. Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4C (39F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the delicate glycoprotein structures.

Referenced Citations

References are provided for informational purposes only and are not clinical claims.

• Santi, D., Casarini, L., Alviggi, C., & Simoni, M. (2020). Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Poor Responder” (POSEIDON Criteria). Frontiers in Endocrinology, 11, 401. https://doi.org/10.3389/fendo.2020.00401
• Lazzaretti, C., Paradiso, E., Baraldi, E., et al. (2021). The Choice of Gonadotropins for Ovarian Stimulation. International Journal of Molecular Sciences, 22(22), 12519. https://doi.org/10.3390/ijms222212519
• Smitz, J., Andersen, C. Y., & Devroey, P. (2020). Endocrine profile and ovarian response in women treated with highly purified human menopausal gonadotropin. Reproductive Biology and Endocrinology, 18(1), 38.https://pubmed.ncbi.nlm.nih.gov/17110397/
• Alviggi, C., Conforti, A., Esteves, S. C., et al. (2023). A new perspective on the use of recombinant luteinizing hormone and human menopausal gonadotropin in assisted reproductive technology. Frontiers in Endocrinology, 14, 1166444.https://pubmed.ncbi.nlm.nih.gov/40059197/

Casarini, L., & Crépieux, P. (2020). Molecular Mechanisms of Action of FSH. Frontiers in Endocrinology, 10, 305. https://doi.org/10.3389/fendo.2019.00305

• Stable at room temperature for up to 90 days. For long-term storage, keep at -20°C (-4°F) or colder.
• Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4 °C (39°F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the peptide structure.

RESEARCH USE ONLY

This product is intended strictly for laboratory research use only. It is not for human or veterinary use. It is not intended for diagnosis, treatment, cure, or prevention of any disease. All purchases are subject to our Terms of Service and Purity Guarantee.

No COAs available for this product.